Cargando…

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma

BACKGROUND: The Intratumoral Microvessel Density (IMVD) is commonly used to quantify tumoral vascularization and is usually assessed by pan-endothelial markers, such as CD31. Endoglin (CD105) is a protein predominantly expressed in proliferating endothelium and the IMVD determined by this marker mea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Paolo, Virginia, Russo, Ida, Boldrini, Renata, Ravà, Lucilla, Pezzullo, Marco, Benedetti, Maria Chiara, Galardi, Angela, Colletti, Marta, Rota, Rossella, Orlando, Domenico, Crocoli, Alessandro, Peinado, Hector, Milano, Giuseppe Maria, Di Giannatale, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755407/ https://www.ncbi.nlm.nih.gov/pubmed/29304781 http://dx.doi.org/10.1186/s12885-017-3947-4

Ejemplares similares

Congenital Rhabdomyosarcoma: a different clinical presentation in two cases
por: Russo, Ida, et al.
Publicado: (2018)

Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript
por: Colletti, Marta, et al.
Publicado: (2021)

Exosomal MiRNAs in Pediatric Cancers
por: Galardi, Angela, et al.
Publicado: (2019)

An Update on Circular RNA in Pediatric Cancers
por: Galardi, Angela, et al.
Publicado: (2022)

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas
por: Russo, Ida, et al.
Publicado: (2020)

Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
por: Colletti, Marta, et al.
Publicado: (2019)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression
por: Perrone, Clara, et al.
Publicado: (2022)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Proteomic Profiling of Retinoblastoma-Derived Exosomes Reveals Potential Biomarkers of Vitreous Seeding
por: Galardi, Angela, et al.
Publicado: (2020)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Proteomics of Aqueous Humor as a Source of Disease Biomarkers in Retinoblastoma
por: Galardi, Angela, et al.
Publicado: (2022)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Endoglin Expression and Microvessel Density as Prognostic Factors in Pediatric Rhabdomyosarcoma
por: Radzikowska, Joanna, et al.
Publicado: (2021)

Study of expression of endoglin (CD105) in oral squamous cell carcinoma
por: Mahapatra, Niva, et al.
Publicado: (2021)

DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor (CIC) Alterations
por: Miele, Evelina, et al.
Publicado: (2020)

Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
por: Kasprzak, Aldona, et al.
Publicado: (2018)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Neuroblastoma-secreted exosomes carrying miR‐375 promote osteogenic differentiation of bone-marrow mesenchymal stromal cells
por: Colletti, Marta, et al.
Publicado: (2020)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
por: Bock, Annika J., et al.
Publicado: (2011)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2020)

Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

Horoscopic role of CD105 (Endoglin) in progression of oral lichen planus: An immunohistochemical study
por: Parvathala, Poornima, et al.
Publicado: (2021)

Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
por: Bastos, António G. P., et al.
Publicado: (2022)

Autophagy and Exosomes Relationship in Cancer: Friends or Foes?
por: Colletti, Marta, et al.
Publicado: (2021)

Recent Advancements on the Use of Exosomes as Drug Carriers for the Treatment of Glioblastoma
por: Galardi, Angela, et al.
Publicado: (2023)

HGG-16. EXOSOME-MEDIATED INTER-CLONAL INTERACTIONS IN PEDIATRIC GBM AND DIPG
por: Pericoli, Giulia, et al.
Publicado: (2020)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

Endoglin in the Spotlight to Treat Cancer
por: González Muñoz, Teresa, et al.
Publicado: (2021)

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer
por: Fonsatti, Ester, et al.
Publicado: (2004)

Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review
por: Sur, Daniel, et al.
Publicado: (2022)

MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
por: Vella, Serena, et al.
Publicado: (2015)

Microglial Phenotyping in Neurodegenerative Disease Brains: Identification of Reactive Microglia with an Antibody to Variant of CD105/Endoglin
por: Walker, Douglas G., et al.
Publicado: (2019)

HGG-19. IDENTIFICATION OF NOVEL SUBGROUP-SPECIFIC miRNA EXOSOMAL BIOMARKERS IN PEDIATRIC HIGH-GRADE GLIOMAS
por: Petrilli, Lucia Lisa, et al.
Publicado: (2020)

Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer
por: Liu, Yingmiao, et al.
Publicado: (2014)

The New Deal: A Potential Role for Secreted Vesicles in Innate Immunity and Tumor Progression
por: Benito-Martin, Alberto, et al.
Publicado: (2015)

Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells
por: De Salvo, Maria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nlaja0ochnt19dcdpdk6uqelmi